Follow
Peter Kenneth Gillman
Peter Kenneth Gillman
Other namesKen Gillman, P Ken Gillman
PsychoTropical research
Verified email at psychotropical.com - Homepage
Title
Cited by
Cited by
Year
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
PK Gillman
British journal of pharmacology 151 (6), 737-748, 2007
8152007
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
PK Gillman
British journal of anaesthesia 95 (4), 434-441, 2005
5442005
The serotonin syndrome and its treatment
PK Gillman
Journal of Psychopharmacology 13 (1), 100-109, 1999
3951999
Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction
RR Ramsay, C Dunford, PK Gillman
British journal of pharmacology 152 (6), 946-951, 2007
3172007
A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action
PK Gillman
Biological psychiatry 59 (11), 1046-1051, 2006
3062006
Serotonin toxicity associated with the use of linezolid: a review of postmarketing data
KR Lawrence, M Adra, PK Gillman
Clinical infectious diseases 42 (11), 1578-1583, 2006
2292006
CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
PK Gillman
Journal of psychopharmacology 25 (3), 429-436, 2011
2122011
Serotonin syndrome: history and risk
PK Gillman
Fundamental & clinical pharmacology 12 (5), 482-491, 1998
1961998
Selective inhibitors of monoamine oxidase type B and the “cheese effect”
JPM Finberg, K Gillman
International review of neurobiology 100, 169-190, 2011
1412011
Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review
P Ken Gillman
Headache: The Journal of Head and Face Pain 50 (2), 264-272, 2010
1202010
Methylene blue implicated in potentially fatal serotonin toxicity
PK Gillman
Anaesthesia 61 (10), 1013-1014, 2006
1202006
Neuroleptic malignant syndrome: mechanisms, interactions, and causality
PK Gillman
Movement Disorders 25 (12), 1780-1790, 2010
1132010
A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status
PK Gillman
Human Psychopharmacology: Clinical and Experimental 21 (2), 117-125, 2006
892006
Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors
PK Gillman
Journal of clinical psychopharmacology 31 (1), 66-74, 2011
852011
Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium
SC Stanford, BJ Stanford, PK Gillman
Journal of Psychopharmacology 24 (10), 1433-1438, 2010
852010
Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan
PK Gillman, JR Bartlett, PK Bridges, A Hunt, AJ Patel, BD Kantamaneni, ...
Journal of Neurochemistry 37 (2), 410-417, 1981
811981
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths
PK Gillman
Journal of Neural Transmission 125 (11), 1707-1717, 2018
752018
Human platelet phenolsulphotransferase: separate control of the two forms and activity range in depressive illness
SMB Carter, V Glover, M Sandler, PK Gillman, PK Bridges
Clinica Chimica Acta 117 (3), 333-344, 1981
631981
Fatal methylene blue associated serotonin toxicity
WMC Top, PK Gillman, CJ De Langen, A Kooy
Netherlands Journal of Medicine 72 (3), 179-181, 2014
572014
Possible serotonin syndrome with moclobemide and pethidine
PK Gillman
The Medical Journal of Australia 162 (10), 554, 1995
561995
The system can't perform the operation now. Try again later.
Articles 1–20